HOME >> MEDICINE >> NEWS
Implantable defibrillators cost-effective for preventing sudden death

DALLAS, April 16 In the first study of its kind, an implantable cardioverter defibrillator (ICD), a device used to treat heart rhythm abnormalities, was found to be moderately cost-effective for preventing sudden cardiac death, according to a report in todays rapid access Circulation: Journal of the American Heart Association.

ICDs deliver electrical shocks to the heart to eliminate abnormal rhythms such as ventricular fibrillation or ventricular tachycardia. In the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial, the device was shown to be superior to therapy with antiarrhythmic medications for reducing all causes of death in survivors of ventricular fibrillation (irregular, chaotic heart rhythm that begins in the hearts lower chambers). It was also a better choice for people with ventricular tachycardia (an often serious rapid rhythm originating in the lower chambers) and ejection fractions of 40 percent or less. Ejection fraction is a measure of the hearts pumping ability.

AVID is the first study to prospectively determine the cost-effectiveness of ICDs for secondary prevention in the United States, according to lead author Greg Larsen, M.D, a staff cardiologist at the Portland VA Medical Center and associate professor of medicine at the Oregon Health and Sciences University, Portland, Oregon. The study looked only at treating patients who had had life-threatening arrhythmias and were at risk for another life-threatening event. Researchers compared life gained and costs due to ICD treatment with that of antiarrhythmic drug therapy.

To find out which treatment was more cost-effective, researchers compiled data on charges for initial and repeat hospitalizations, emergency room and day surgery stays, and the costs of antiarrhythmic drugs from 1,008 patients. These included 505 patients with an ICD. Detailed records of all other medical encounters and expenses, including outpatient services and prescription costs, were
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
15-Apr-2002


Page: 1 2 3

Related medicine news :

1. Implantable heart defibrillators
2. Statement: Implantable medical identification chip
3. Implantable cardiac defibrillator use significantly lowers heart failure mortality
4. Implantable device pumps up ailing heart
5. Implantable heart device reduces deaths by one-third
6. Implanted defibrillators cut heart patients death risk, some more than others
7. Implanted defibrillators not covered for half of patients who could benefit, study finds
8. More doubts over value of defibrillators
9. One use every seven years makes automated external defibrillators a good buy
10. Benefit of public defibrillators is marginal
11. Health and fitness facilities need defibrillators

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
(Date:6/24/2016)... ... , ... Finally, a bruise cream that really works. Originally designed to ... the post-surgical treatment plans of a variety of other procedures including, but not limited ... for bruising and causes a rapid resolution of bruising and inflammatory changes compared to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... SpiritQuest Sedona ... heart of West Sedona, surrounded by famous vortex sites: Cathedral Rock, Airport Mesa, and ... partner properties – the Lodge at Sedona as well as the Sedona Rouge, both ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and recruiting support, is pleased to announce the promotion of Mike Mackey to ... the Market Manager where he was responsible for managing client projects and overseeing ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Consumers have taken a ... have placed more emphasis on patient outcomes. ... programs in the pharmaceutical industry have evolved beyond ... pharmaceutical companies are focusing on becoming more patient-oriented ... products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
Breaking Medicine Technology:
Cached News: